(Q33943332)

30 July 2017

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study (English)

1 reference

30 July 2017

0 references

5

Långström B

1 reference

30 July 2017

Gefvert O

1

1 reference

30 July 2017

Lundberg T

2

1 reference

30 July 2017

Wieselgren IM

3

1 reference

30 July 2017

Bergström M

4

1 reference

30 July 2017

Wiesel F

6

1 reference

30 July 2017

Lindström L

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

European Neuropsychopharmacology

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

105-110

1 reference

30 July 2017

2

1 reference

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Receptor binding and selectivity of three 11C-labelled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Distribution volume ratios without blood sampling from graphical analysis of PET data

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2800%2900133-4

7 January 2021

10.1016/S0924-977X(00)00133-4

Identifiers

DOI

1 reference

30 July 2017

1 reference